Lisa G. Ensign
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Epidemiology
- Pathology and Forensic Medicine
- Surgery
- Co-authors
- Harold M. MaurerEdmund A. GehanMoody D. WharamPeter F. ThallAdel K. El‐NaggarR. Beverly RaneyWilliam A. NewtonMerrick I. Ross
- Topics
- Antifungal resistance and susceptibility (3 papers)Renal and related cancers (3 papers)Sarcoma Diagnosis and Treatment (3 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Lisa G. Ensign
15 papers receiving 648 citations
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 235
- Oncology 188
- Epidemiology 138
- Pathology and Forensic Medicine 114
- Surgery 102
Countries citing papers authored by Lisa G. Ensign
This map shows the geographic impact of Lisa G. Ensign's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa G. Ensign with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa G. Ensign more than expected).
Fields of papers citing papers by Lisa G. Ensign
This network shows the impact of papers produced by Lisa G. Ensign. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa G. Ensign. The network helps show where Lisa G. Ensign may publish in the future.
Co-authorship network of co-authors of Lisa G. Ensign
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa G. Ensign. A scholar is included among the top collaborators of Lisa G. Ensign based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa G. Ensign. Lisa G. Ensign is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 26 | |
| 3 | 2 | |
| 4 | 68 | |
| 5 | 52 | |
| 6 | 25 | |
| 7 | 88 | |
| 8 | 17 | |
| 9 | 89 | |
| 10 | 55 | |
| 11 | Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. | 43 |
| 12 | 136 | |
| 13 | 26 | |
| 14 | 8 | |
| 15 | 33 |
About Lisa G. Ensign
Lisa G. Ensign is a scholar working on Medical Laboratory Technology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 669 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Renal and related cancers (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Statistics and Probability (69 citations), Pulmonary and Respiratory Medicine (235 citations) and Oncology (188 citations). Lisa G. Ensign has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Harold M. Maurer, Edmund A. Gehan, Moody D. Wharam, Peter F. Thall, Adel K. El‐Naggar, R. Beverly Raney, William A. Newton, Merrick I. Ross, Keith M. Heaton and R Heyn. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.